|
|
Volumn 29, Issue 7, 1997, Pages 3135-3136
|
|
A randomized clinical trial using ATG Fresenius or ATG Merieux as induction therapy in kidney transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATG FRESENIUS;
ATG MERIEUX;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
ADULT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
DRUG SAFETY;
ECONOMIC ASPECT;
FEMALE;
FEVER;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
LIVER FUNCTION TEST;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
ANIMALS;
ANTILYMPHOCYTE SERUM;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LEUKOCYTE COUNT;
MALE;
MIDDLE AGED;
RABBITS;
|
|
EID: 0030729044
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(97)00813-0 Document Type: Conference Paper |
|
Times cited : (15)
|
|
References (2)
|
